280 related articles for article (PubMed ID: 11882909)
1. New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.
Berki T; Dávid M; Bóné B; Losonczy H; Vass J; Németh P
Pathol Oncol Res; 2001; 7(4):292-7. PubMed ID: 11882909
[TBL] [Abstract][Full Text] [Related]
2. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
Tajima K; Katagiri T
Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
[TBL] [Abstract][Full Text] [Related]
3. Marked and persistent eosinophilia in the absence of clinical manifestations.
Chen YY; Khoury P; Ware JM; Holland-Thomas NC; Stoddard JL; Gurprasad S; Waldner AJ; Klion AD
J Allergy Clin Immunol; 2014 Apr; 133(4):1195-202. PubMed ID: 23987798
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5.
Trüeb RM; Lübbe J; Torricelli R; Panizzon RG; Wüthrich B; Burg G
Arch Dermatol; 1997 Feb; 133(2):203-6. PubMed ID: 9041834
[TBL] [Abstract][Full Text] [Related]
5. Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators.
Aldebert D; Lamkhioued B; Desaint C; Gounni AS; Goldman M; Capron A; Prin L; Capron M
Blood; 1996 Mar; 87(6):2354-60. PubMed ID: 8630398
[TBL] [Abstract][Full Text] [Related]
6. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.
Roufosse F; de Lavareille A; Schandené L; Cogan E; Georgelas A; Wagner L; Xi L; Raffeld M; Goldman M; Gleich GJ; Klion A
J Allergy Clin Immunol; 2010 Oct; 126(4):828-835.e3. PubMed ID: 20810155
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilia associated with clonal T-cell proliferation.
Kitano K; Ichikawa N; Shimodaira S; Ito T; Ishida F; Kiyosawa K
Leuk Lymphoma; 1997 Oct; 27(3-4):335-42. PubMed ID: 9402331
[TBL] [Abstract][Full Text] [Related]
10. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
[TBL] [Abstract][Full Text] [Related]
11. IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients.
Jenne L; Kilwinski J; Scheffold W; Kern P
Clin Exp Immunol; 1997 Jul; 109(1):90-7. PubMed ID: 9218830
[TBL] [Abstract][Full Text] [Related]
12. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
13. Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes.
Schuerwegh AJ; De Clerck LS; Bridts CH; Stevens WJ
Clin Exp Allergy; 2001 May; 31(5):740-6. PubMed ID: 11422133
[TBL] [Abstract][Full Text] [Related]
14. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
[TBL] [Abstract][Full Text] [Related]
15. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
Schmid-Grendelmeier P; Altznauer F; Fischer B; Bizer C; Straumann A; Menz G; Blaser K; Wüthrich B; Simon HU
J Immunol; 2002 Jul; 169(2):1021-7. PubMed ID: 12097410
[TBL] [Abstract][Full Text] [Related]
16. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.
Bobbio-Pallavicini E; Confalonieri M; Tacconi F; Mainardi E; Della Porta R; Ceccato D; Maccario R; De Amici M
Panminerva Med; 1998 Sep; 40(3):186-90. PubMed ID: 9785914
[TBL] [Abstract][Full Text] [Related]
17. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
Lampinen M; Oberg G; Venge P; Carlson M
APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
[TBL] [Abstract][Full Text] [Related]
18. Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.
Zimmermann N; Wikenheiser-Brokamp KA
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):179-185. PubMed ID: 29803709
[TBL] [Abstract][Full Text] [Related]
19. Identification of surface molecules on eosinophils and lymphocytes in blood from patients with eosinophilia.
Enokihara H; Koike T; Nakamura Y; Saito K; Furusawa S
Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():72-4. PubMed ID: 9363931
[TBL] [Abstract][Full Text] [Related]
20. Hypereosinophilic syndrome: case presentation and update.
Leiferman KM; Gleich GJ
J Allergy Clin Immunol; 2004 Jan; 113(1):50-8. PubMed ID: 14713907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]